Full Text View
Tabular View
No Study Results Posted
Related Studies
Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous Infusion
This study has been terminated.
( difficulties by enrolling patients fundings consumed, no staff could be recruited and payed to continue enrolling patients, )
Study NCT00435305   Information provided by University Hospital Tuebingen

First Received on February 13, 2007.   Last Updated on June 6, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pneumonia
Bacteremia
More general conditions related to this trial
Bacterial Infections
Infection
Inflammation
Lung Diseases
Pathologic Processes
Respiratory Tract Diseases
Respiratory Tract Infections
Sepsis
Systemic Inflammatory Response Syndrome
Interventions listed in this trial
Meropenem
Vancomycin
Linezolid
Piperacillin/Tazobactam
Cefepim
Ceftazidim
Additional drug interventions recognized in this trial
Anti-Bacterial Agents
Cefepime
Ceftazidime
Penicillanic Acid
Piperacillin
Piperacillin-tazobactam combination product
Tazobactam
More general drug interventions related to this trial
Anti-Infective Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Synthesis Inhibitors
Therapeutic Uses
Sponsors listed in this trial
University Hospital Tuebingen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services